TrialNature medicine2025

Ubrogepant for the treatment of migraine prodromal symptoms: an exploratory analysis from the randomized phase 3 PRODROME trial.

Peter J Goadsby et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.